CHEMOURS CO/THE (CC)

US1638511089 - Common Stock

17.33  -0.21 (-1.2%)

After market: 17.616 +0.29 (+1.65%)

Fundamental Rating

3

Taking everything into account, CC scores 3 out of 10 in our fundamental rating. CC was compared to 83 industry peers in the Chemicals industry. Both the profitability and financial health of CC have multiple concerns. CC has a valuation in line with the averages, but it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

CC had positive earnings in the past year.
In the past year CC has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: CC reported negative net income in multiple years.
Each year in the past 5 years CC had a positive operating cash flow.

1.2 Ratios

The Return On Assets of CC (0.92%) is worse than 60.24% of its industry peers.
CC has a better Return On Equity (10.50%) than 72.29% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.17%, CC is in line with its industry, outperforming 57.83% of the companies in the same industry.
Industry RankSector Rank
ROA 0.92%
ROE 10.5%
ROIC 5.17%
ROA(3y)4.24%
ROA(5y)3.02%
ROE(3y)25.39%
ROE(5y)19.11%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 1.20%, CC is not doing good in the industry: 60.24% of the companies in the same industry are doing better.
The Operating Margin of CC (6.56%) is worse than 60.24% of its industry peers.
CC has a worse Gross Margin (19.57%) than 65.06% of its industry peers.
CC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.56%
PM (TTM) 1.2%
GM 19.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.3%
GM growth 5Y-6.11%

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CC is destroying value.
CC has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CC has been reduced compared to 5 years ago.
Compared to 1 year ago, CC has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.71, we must say that CC is in the distress zone and has some risk of bankruptcy.
CC's Altman-Z score of 1.71 is on the low side compared to the rest of the industry. CC is outperformed by 60.24% of its industry peers.
A Debt/Equity ratio of 6.07 is on the high side and indicates that CC has dependencies on debt financing.
CC's Debt to Equity ratio of 6.07 is on the low side compared to the rest of the industry. CC is outperformed by 93.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.07
Debt/FCF N/A
Altman-Z 1.71
ROIC/WACC0.69
WACC7.5%

2.3 Liquidity

CC has a Current Ratio of 1.73. This is a normal value and indicates that CC is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CC (1.73) is worse than 60.24% of its industry peers.
A Quick Ratio of 0.92 indicates that CC may have some problems paying its short term obligations.
CC has a Quick ratio of 0.92. This is in the lower half of the industry: CC underperforms 73.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 0.92

3

3. Growth

3.1 Past

The earnings per share for CC have decreased strongly by -47.97% in the last year.
CC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.81% yearly.
CC shows a decrease in Revenue. In the last year, the revenue decreased by -4.23%.
The Revenue has been decreasing by -1.91% on average over the past years.
EPS 1Y (TTM)-47.97%
EPS 3Y15.3%
EPS 5Y-11.81%
EPS Q2Q%-36.51%
Revenue 1Y (TTM)-4.23%
Revenue growth 3Y6.65%
Revenue growth 5Y-1.91%
Sales Q2Q%0.94%

3.2 Future

CC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.03% yearly.
Based on estimates for the next years, CC will show a small growth in Revenue. The Revenue will grow by 2.22% on average per year.
EPS Next Y-56.51%
EPS Next 2Y-11.89%
EPS Next 3Y3.03%
EPS Next 5YN/A
Revenue Next Year-3.84%
Revenue Next 2Y0.52%
Revenue Next 3Y2.22%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.29 indicates a correct valuation of CC.
Compared to the rest of the industry, the Price/Earnings ratio of CC indicates a rather cheap valuation: CC is cheaper than 83.13% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.55. CC is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 7.39, the valuation of CC can be described as very cheap.
CC's Price/Forward Earnings ratio is rather cheap when compared to the industry. CC is cheaper than 91.57% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.00, CC is valued rather cheaply.
Industry RankSector Rank
PE 12.29
Fwd PE 7.39

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CC is valued a bit cheaper than the industry average as 65.06% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.89%
EPS Next 3Y3.03%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.72%, CC is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.35, CC pays a better dividend. On top of this CC pays more dividend than 90.36% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, CC pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.72%

5.2 History

The dividend of CC has a limited annual growth rate of 3.70%.
CC has paid a dividend for at least 10 years, which is a reliable track record.
CC has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)3.7%
Div Incr Years0
Div Non Decr Years8

5.3 Sustainability

CC pays out 215.94% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CC is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP215.94%
EPS Next 2Y-11.89%
EPS Next 3Y3.03%

CHEMOURS CO/THE

NYSE:CC (12/26/2024, 8:04:00 PM)

After market: 17.616 +0.29 (+1.65%)

17.33

-0.21 (-1.2%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-04 2024-11-04/bmo
Earnings (Next)N/A N/A
Inst Owners79.54%
Inst Owner Change4.79%
Ins Owners0.3%
Ins Owner Change4.24%
Market Cap2.59B
Analysts72.63
Price Target26.18 (51.07%)
Short Float %4.91%
Short Ratio4.29
Dividend
Industry RankSector Rank
Dividend Yield 5.72%
Dividend Growth(5Y)3.7%
DP215.94%
Div Incr Years0
Div Non Decr Years8
Ex-Date11-15 2024-11-15 (0.25)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.65%
Min EPS beat(2)-35.5%
Max EPS beat(2)36.8%
EPS beat(4)3
Avg EPS beat(4)22.45%
Min EPS beat(4)-35.5%
Max EPS beat(4)69.9%
EPS beat(8)4
Avg EPS beat(8)10.15%
EPS beat(12)7
Avg EPS beat(12)13.62%
EPS beat(16)11
Avg EPS beat(16)16.26%
Revenue beat(2)1
Avg Revenue beat(2)-0.67%
Min Revenue beat(2)-2.41%
Max Revenue beat(2)1.08%
Revenue beat(4)2
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-2.88%
Max Revenue beat(4)1.08%
Revenue beat(8)4
Avg Revenue beat(8)-1.19%
Revenue beat(12)7
Avg Revenue beat(12)0.11%
Revenue beat(16)10
Avg Revenue beat(16)0.68%
PT rev (1m)-2.53%
PT rev (3m)-9.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-56.24%
EPS NY rev (1m)-0.73%
EPS NY rev (3m)-1.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.9%
Revenue NY rev (1m)0.54%
Revenue NY rev (3m)1%
Valuation
Industry RankSector Rank
PE 12.29
Fwd PE 7.39
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 3.94
P/tB 4.26
EV/EBITDA 9
EPS(TTM)1.41
EY8.14%
EPS(NY)2.34
Fwd EY13.53%
FCF(TTM)-4.5
FCFYN/A
OCF(TTM)-1.92
OCFYN/A
SpS38.48
BVpS4.4
TBVpS4.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.92%
ROE 10.5%
ROCE 6.63%
ROIC 5.17%
ROICexc 5.78%
ROICexgc 5.83%
OM 6.56%
PM (TTM) 1.2%
GM 19.57%
FCFM N/A
ROA(3y)4.24%
ROA(5y)3.02%
ROE(3y)25.39%
ROE(5y)19.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.3%
GM growth 5Y-6.11%
F-Score4
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 6.07
Debt/FCF N/A
Debt/EBITDA 5.92
Cap/Depr 129.97%
Cap/Sales 6.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 0.92
Altman-Z 1.71
F-Score4
WACC7.5%
ROIC/WACC0.69
Cap/Depr(3y)104.47%
Cap/Depr(5y)110.3%
Cap/Sales(3y)5.01%
Cap/Sales(5y)5.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.97%
EPS 3Y15.3%
EPS 5Y-11.81%
EPS Q2Q%-36.51%
EPS Next Y-56.51%
EPS Next 2Y-11.89%
EPS Next 3Y3.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.23%
Revenue growth 3Y6.65%
Revenue growth 5Y-1.91%
Sales Q2Q%0.94%
Revenue Next Year-3.84%
Revenue Next 2Y0.52%
Revenue Next 3Y2.22%
Revenue Next 5YN/A
EBIT growth 1Y501.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5.59%
EBIT Next 3Y15.35%
EBIT Next 5YN/A
FCF growth 1Y-238.76%
FCF growth 3Y-29.9%
FCF growth 5Y-21.95%
OCF growth 1Y-135.52%
OCF growth 3Y-11.68%
OCF growth 5Y-13.38%